SCHEMBL9380107

SCHEMBL9380107

CCCCC1C(=O)N(c2ccccc2)N=C1Cn1ccnc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 9/20 0.46
CYP3A4 P08684 3/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP1A2 P05177 2/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
CYP2C9 P11712 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41
TP53 P04637 1/20 0.41
HPGD P15428 1/20 0.41
PTGS1 P23219 1/20 0.41
RAB9A P51151 1/20 0.41
NAPRT Q6XQN6 1/20 0.41
CYP11B1 P15538 4/20 0.41
CYP11B2 P19099 4/20 0.41
CYP19A1 P11511 3/20 0.41
POLB P06746 1/20 0.41
CYP2D6 P10635 1/20 0.41
TBXAS1 P24557 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9382448 0.91 CYP19A1 (0.45) CES2ALDH1A1RAB9ACYP11B1CYP11B2
SCHEMBL9382915 0.89 CYP19A1 (0.44) CES2CYP3A4ALDH1A1CYP1A2CYP2C9
SCHEMBL9378469 0.89 CYP11B1 (0.46) CES2CYP3A4ALDH1A1CYP1A2MAPT
SCHEMBL9378296 0.89 CES2 (0.55) CES2CYP3A4CYP1A2MAPTCYP11B1
SCHEMBL9379946 0.88 TBXAS1 (0.41) CES2LMNACYP11B1CYP11B2CYP19A1
SCHEMBL9379777 0.87 CYP19A1 (0.43) CES2ALDH1A1CYP11B1CYP11B2CYP19A1
SCHEMBL9383381 0.87 CYP11B1 (0.36) CYP3A4CYP1A2MAPTLMNATP53
SCHEMBL9378758 0.84 SIGMAR1 (0.39) LMNACYP11B1CYP11B2CYP19A1CYP17A1
SCHEMBL9378248 0.81 LOX (0.50) CES2CYP3A4CYP1A2MAPTCYP11B1
SCHEMBL9380139 0.81 TBXAS1 (0.41) CES2LMNACYP11B1CYP11B2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0269030-B1 Lipid-peroxide formation inhibiting composition and novel compounds useful therefor MITSUBISHI CHEM IND (JP) 1994-05-04 EP disclosed
US-5089515-A Antiischemic agents; pyrazolone compounds MITSUBISHI KASEI CORPORATION (JP) 1992-02-18 US disclosed
US-4990619-A Cardiovascular disorders, antiischemic agents MITSUBISHI KASEI CORPORATION (JP) 1991-02-05 US disclosed
US-4906644-A Lipid-peroxide formation inhibiting composition and novel compounds useful therefor MITSUBISHI KASEI CORPORATION (JP) 1990-03-06 US disclosed